Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
BMC Neurology|January 31, 2024
Exploring humanistic burden of fatigue in adults with multiple sclerosis: an analysis of US National Health and Wellness Survey dataHoa H Le, Jennifer Ken-Opurum, Anne LaPrade, et al.
Human Psychopharmacology|October 3, 2014
How well do clinicians and patients agree on depression treatment outcomes? Implications for personalized medicineBoadie W Dunlop, Bhrett McCabe, James M Eudicone, et al.
Magnetic Resonance in Medicine|September 23, 2010
Highly accelerated contrast-enhanced MR angiography: improved reconstruction accuracy and reduced noise amplification with complex subtractionIoannis Koktzoglou, John J Sheehan, Eugene E Dunkle, et al.
Multiple Sclerosis and Related Disorders|July 17, 2022
Assessment of economic burden of fatigue in adults with multiple sclerosis: An analysis of US National Health and Wellness Survey dataHoa H Le, Jennifer Ken-Opurum, Anne LaPrade, et al.
Magnetic Resonance in Medicine|April 8, 2010
Quiescent-interval single-shot unenhanced magnetic resonance angiography of peripheral vascular disease: Technical considerations and clinical feasibilityRobert R Edelman, John J Sheehan, Eugene Dunkle, et al.
Journal of Affective Disorders|May 26, 2019
Is clinician impression of depression symptom severity associated with incremental economic burden in privately insured US patients with treatment resistant depression?Dominic Pilon, John J Sheehan, Holly Szukis, et al.
Journal of Comparative Effectiveness Research|January 25, 2022
US budget impact analysis of esketamine nasal spray in major depressive disorder with acute suicidal ideation/behaviorJennifer Voelker, John J Sheehan, Hoa H Le, et al.
Journal of Managed Care & Specialty Pharmacy|April 1, 2020
Pitfalls of Cost-Effectiveness Analysis in Practice: A TRD Case Example in the United States with Esketamine Versus Oral AntidepressantsSwapna Karkare, Hoa H Le, John J Sheehan, et al.
The Journal of Clinical Psychiatry|May 14, 2021
The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United StatesMaryia Zhdanava, Dominic Pilon, Isabelle Ghelerter, et al.
Therapeutic Innovation & Regulatory Science|January 4, 2021
Real-World Data for Planning Eligibility Criteria and Enhancing Recruitment: Recommendations from the Clinical Trials Transformation InitiativeScott R Evans, Dianne Paraoan, Jane Perlmutter, et al.
Pageof 9